NEW YORK (GenomeWeb) – Great Basin Scientific announced today that it has completed a clinical trial and 510(k) submission to the US Food and Drug Administration for its Bordetella Direct Test for Bordetella pertussis, the infectious agent that causes whooping cough. The company is also seeking a CE mark for the test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.